Yufengchang Holdings (08631) plans to sell up to 8 million shares with a net fundraising of approximately HK$2.8 million.

22:32 16/01/2026

Yufeng Chang Holdings (08631) announced that on January 16, 2026 (after the trading hours of the Stock Exchange of Hong Kong), the company entered into a placing agreement with a placing agent to place a maximum of 8 million shares to no less than six placing agents at a price of HK$0.39 per share, with a maximum net proceeds of approximately HK$2.8 million, intended for settling unpaid fees to professional service providers and other outstanding expenses; as well as for general working capital of the group.

YUFENGCHANG HLD(08631) announced that on January 16, 2026 (after the trading session on the Stock Exchange of Hong Kong), the company entered into a placing agreement with placement agents. It plans to issue a maximum of 8 million shares at a price of HK$0.39 per share to at least six placees, raising a maximum of approximately HK$2.8 million. The funds raised will be used to settle unpaid expenses to professional service providers and other outstanding expenses, as well as for general operational purposes of the group.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.

HK Stock Market Move | NATURAL FOOD IH(01837) continues to rise by over 5%, offline channel business significantly grows, with annual net profit increasing by approximately 40% compared to the previous year.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.